Dibenzazepine, a γ-Secretase Enzyme Inhibitor, Protects Against Doxorubicin-Induced Cardiotoxicity by Suppressing NF-κB, iNOS, and Hes1/Hey1 Expression
Article in Inflammation (July 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Inflammation (July 2024)
Article in Reviews in Endocrine and Metabolic Disorders (September 2021)
Article in Proceedings of the National Academy of Sciences of the United States of America (September 2021)